Re-appointment of Mr. Bharat Brijmohan Sharma as Managing Director for a further period of Three years effective from April 01, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ganga Pharmaceuticals has re-appointed Mr. Bharat Brijmohan Sharma as Managing Director for another three-year term starting April 1, 2026. The decision was made at a board meeting on March 10, 2026, based on the recommendation of the Nomination and Remuneration Committee and Audit Committee. Mr. Sharma has over 35 years of experience in the business and pharma industry and is not debarred from holding director office by any SEBI order. The re-appointment is subject to shareholder approval, and Mr. Sharma will not be liable to retire by rotation. His spouse, Mrs. Srijna Sharma, is a Whole-time Director at the company, indicating a family-run leadership structure.
This is a continuity announcement with no change in leadership direction, so near-term stock impact is expected to be minimal. Shareholders will get to vote on the re-appointment at the next general meeting.